Key Takeaways
- DocuSign reported Q2 FY2027 revenue of $875.7 million, up 9% year over year, while non-GAAP diluted EPS reached $1.16 and non-GAAP operating margin expanded to 31.6%.
- Intelligent Agreement Management, or IAM, rose to 15.1% of total ARR from 12.6% one quarter earlier, making the platform transition the most important driver of the investment case.
- Management raised full-year revenue guidance to $3.499 billion-$3.507 billion, increased ARR growth guidance to 8.5%-9.0%, and now expects IAM to reach 18%-19% of total ARR exiting Q4.
- The quality of the margin beat was good but not perfect: management said roughly half came from stronger revenue flow-through, while the remainder came from cost discipline and higher capitalization of software-development costs.
- At roughly $67 per share around September 11, 2026, DOCU trades at a valuation that still assumes only moderate top-line acceleration despite strong free-cash-flow generation; the key debate is whether IAM can sustain expansion-led retention gains without materially eroding gross margin.
DocuSign’s fiscal second quarter of 2027, which ended July 31, 2026 and was reported on September 3, delivered a cleaner fundamental picture than the headline revenue growth rate alone suggests. The company is still growing at a high-single-digit pace, but the mix of that growth is improving: IAM adoption is rising, direct-customer dollar net retention is moving higher, large-enterprise customer growth is accelerating, operating leverage is expanding, and management raised the metrics that matter most for the next leg of the story.
The central investment question is no longer whether DocuSign can defend eSignature. It is whether the company can convert its installed base, agreement data, integrations and trust infrastructure into a broader system of action for enterprise agreements. Q2 provided the strongest evidence so far that this transition is gaining commercial traction, but it also highlighted the two risks that investors should not ignore: cloud-migration costs are still pressuring gross margin, and part of the operating-margin upside came from higher software-cost capitalization rather than purely from underlying expense efficiency.
1. Core Earnings Breakdown
Revenue and Profitability Analysis
Total revenue was $875.7 million, up 9% year over year from $800.6 million. Foreign exchange contributed approximately 1.3 percentage points to reported growth, which means the underlying constant-currency growth rate was meaningfully lower than the headline number. Even so, management said that after adjusting for the FX tailwind and an unusually strong comparison in digital add-ons last year, underlying revenue growth accelerated by nearly one percentage point.
- Subscription revenue was $854.0 million versus $784.4 million a year ago, an 8.9% increase and 97.5% of total revenue, calculated from company-reported figures. Investment view: this confirms that DocuSign remains overwhelmingly a recurring-revenue software business, so the durability of retention and upsell matters far more than short-term services volatility.
- Professional services and other revenue was $21.8 million versus $16.2 million, up 34.1% and equal to only 2.5% of total revenue, calculated from company-reported figures. Investment view: the growth is notable but too small to drive the thesis; investors should avoid treating this as a material source of sustainable acceleration.
- International revenue was $272.2 million versus $233.0 million, up 16.8%, while U.S. revenue was $603.5 million versus $567.6 million, up 6.3%, both calculated from company-reported figures. Investment view: international growth is increasingly important to the mix, although part of the reported acceleration benefited from currency.
- IAM represented 15.1% of total ARR, up from 12.6% in Q1. Investment view: this is the most important product-mix signal in the quarter because IAM is the mechanism through which DocuSign is trying to expand beyond eSignature into higher-value workflow, repository, intelligence and agentic use cases.
Profitability was equally important. GAAP gross margin was 79.7%, up from 79.3% a year ago, while non-GAAP gross margin was 81.7%, down slightly from 82.0%. The divergence reflects the fact that cloud migration and AI infrastructure investment are still creating near-term cost pressure even as GAAP operating leverage improves.
Non-GAAP operating income reached $276.8 million, up 16% year over year, and non-GAAP operating margin expanded to 31.6% from 29.8%. GAAP operating income rose to $117.6 million from $65.2 million, with GAAP operating margin improving to 13.4% from 8.1%. Free cash flow was $295.8 million, up from $217.6 million, producing a 34% free-cash-flow margin. That combination of high-single-digit revenue growth and mid-30s free-cash-flow margin is what gives DocuSign strategic flexibility to fund product investment while shrinking the share count.
Non-GAAP diluted EPS was $1.16 versus $0.92 a year ago, while GAAP diluted EPS was $0.40 versus $0.30. The EPS growth benefited from higher operating profit and a lower share count: non-GAAP diluted weighted-average shares fell to 193.1 million from 211.0 million a year earlier.
Expectations vs. Actual Results
- Revenue: $875.7 million actual versus roughly $867.2 million consensus, a beat of about $8.5 million or 1.0%. Result: ✅ Beat.
- Non-GAAP diluted EPS: $1.16 actual versus approximately $1.09 consensus, a beat of $0.07 or about 6.4%. Result: ✅ Beat.
- Non-GAAP operating margin: 31.6% actual versus the company’s prior Q2 guidance range of 29.7%-30.2%. The actual result was about 160 basis points above the prior midpoint on management’s framing. Result: ✅ Beat.
The real source of the earnings beat was broader than simple cost cutting. CFO Blake Grayson said approximately half of the operating-margin outperformance came from stronger revenue flowing through to profit. The remaining half was split roughly evenly between operating-cost discipline, including management of the hiring ramp, and higher capitalization of software-development costs. That distinction matters because only part of the margin upside should be treated as a clean structural improvement in expense efficiency.
The market should care more about ARR, IAM mix, retention and guidance than about the $8.5 million revenue beat by itself. Q3 revenue guidance of $886 million-$890 million implies approximately 9% year-over-year growth at the midpoint and sits almost exactly around the roughly $888.5 million consensus level cited immediately after the report. In other words, the next-quarter revenue guide was not the main source of excitement.
The more important message was the full-year raise. DocuSign now expects FY2027 revenue of $3.499 billion-$3.507 billion, up from its previous $3.490 billion-$3.502 billion range. More importantly, ARR growth guidance increased to 8.5%-9.0%, compared with 8.0% ARR growth in FY2026, and management raised its year-end IAM mix target to 18%-19% of total ARR.
Q3 non-GAAP gross margin is guided to 81.5%-81.9%, while non-GAAP operating margin is guided to 31.3%-31.7%. For the full year, management expects non-GAAP gross margin of 81.5%-82.0% and non-GAAP operating margin of 31.0%-31.5%. This is a favorable setup for earnings quality if the company can sustain IAM-led ARR growth while holding the operating margin above 31%.
The stock reaction broadly matched the quality of the report rather than diverging from it. DOCU closed at $68.41 on September 4, up about 3.7% from the September 3 regular-session close of $65.97. By around September 11, shares were near $67.37, meaning part of the immediate gain had faded but the stock remained modestly above its pre-earnings level. That pattern suggests the market appreciated the ARR and IAM guidance increase but was not willing to assign an aggressive growth re-rating after only one quarter of improved expansion dynamics.
This was therefore not a classic “sell the news” setup. The stock did not collapse despite only modestly higher full-year revenue guidance because investors were rewarded with a better-quality signal: rising IAM penetration, improving DNR, strong enterprise customer growth, higher margins and increased ARR guidance. The restraint in the post-report re-rating likely reflects lingering skepticism over whether high-single-digit revenue growth can become sustainably double digit, how much AI infrastructure will cost, and how much of the operating leverage is repeatable.
Earnings Call Highlights
IAM reached 15.1% of total ARR, and management described it as the main driver of the company’s growth acceleration.
💡 Reading Between the Lines: DocuSign is increasingly asking investors to value the company as an agreement-management platform rather than as a mature eSignature vendor. If IAM continues to gain share of ARR while total ARR growth accelerates, the multiple framework can shift from ex-growth software toward platform software with expansion optionality.
Direct-customer dollar net retention improved to 103%, with expansion contributing more to the improvement than in prior periods.
💡 Reading Between the Lines: This is a more important signal than a one-quarter revenue beat. The company had previously improved retention mainly by reducing churn; a larger expansion contribution suggests IAM is beginning to create genuine upsell economics inside the installed base.
Customers spending more than $300,000 in annual contract value grew 14% year over year to nearly 1,300.
💡 Reading Between the Lines: Enterprise traction is improving faster than the consolidated revenue growth rate. Larger customers are the most logical entry point for multi-product IAM adoption because they have the most complex agreement estates, the greatest compliance burden and the most potential workflow automation value.
Management’s distribution strategy is to make DocuSign agreement intelligence available inside third-party AI and workflow environments rather than forcing customers into a closed interface.
💡 Reading Between the Lines: The MCP strategy is designed to make DocuSign the agreement layer beneath tools such as ChatGPT, Claude, Gemini, Copilot and Slack. This can broaden distribution, but it also introduces a strategic trade-off: third-party AI platforms may own more of the user experience and could eventually pressure value capture if DocuSign’s data and workflow layer is not sufficiently differentiated.
Management said roughly half of the operating-margin beat came from stronger revenue, with the balance split between cost discipline and higher software-cost capitalization.
💡 Reading Between the Lines: The margin upside was economically meaningful, but investors should not extrapolate the full beat as pure structural efficiency. Capitalized development costs shift expense recognition over time, even though management emphasized that the capitalization treatment does not create an incremental free-cash-flow benefit.
2. Deep Business Insights
Hidden Metrics That Matter
First, the new IAM mix guidance implies a much larger IAM revenue base than the headline percentage alone suggests. Fiscal 2026 ARR ended at $3.272 billion. Applying the FY2027 ARR growth guidance of 8.5%-9.0% produces an implied year-end total ARR range of approximately $3.55 billion-$3.57 billion. Applying the 18%-19% IAM mix target to that range produces implied IAM ARR of approximately $639 million-$678 million. Calculation: $3.272 billion × 1.085 × 18% = about $639 million at the low end, and $3.272 billion × 1.09 × 19% = about $678 million at the high end. This is calculated from company-reported figures, not a company-issued IAM ARR forecast.
That range matters because it shows the scale of the platform transition. IAM is not just a product demo story; at the current trajectory it is becoming a several-hundred-million-dollar recurring-revenue business inside DocuSign. The key future test is whether this mix shift drives total ARR growth higher rather than merely reallocating spend from legacy products.
Second, the geographic growth spread is unusually wide. International revenue grew 16.8% year over year versus 6.3% in the U.S., calculated from company-reported figures. Some of that gap reflects FX, but even after acknowledging currency, the international business is becoming a more important growth engine. This has two valuation implications: it expands the addressable base beyond the more mature U.S. eSignature market, but it also increases exposure to currency and regional execution variability.
Why do customers choose DocuSign rather than a generic document or AI tool? The answer is not simply brand recognition. DocuSign combines a large installed base, enterprise identity and permissions, agreement-specific workflows, more than 1,100 third-party integrations and APIs, government-grade security authorizations, and a large proprietary corpus of private, consented agreements used to improve its models. The company says its agreement library contains more than 200 million private, consented agreements and estimates that training on this data can produce up to a 15-percentage-point improvement in precision and recall versus models trained on public contract data, along with a large processing-cost advantage. These are company estimates, but they explain the strategic moat management is trying to build: trusted agreement context plus actionability, not merely text generation.
The Q2 transcript adds another important data point: customers have now ingested more than 300 million documents through IAM Agreement Manager. That suggests the repository is becoming a meaningful data substrate. The more agreements that sit inside the platform, the more useful search, extraction, policy enforcement, renewal management and agentic workflows can become. This can raise switching costs if the platform becomes embedded in legal, procurement, sales and finance processes.
Industry Chain Reactions
- ✅ Benefit — Microsoft (MSFT): DocuSign’s strategy of embedding agreement intelligence into external work environments can increase the utility of Microsoft Copilot and broader Microsoft workflow surfaces. The read-through is ecosystem-positive rather than directly material to Microsoft’s financials: DocuSign is choosing integration over isolation, which can make Copilot a more capable enterprise front end for contract-related work.
- ❌ Face Pressure — Adobe (ADBE): Adobe Acrobat Sign remains a credible eSignature alternative, but DocuSign’s competitive narrative is moving away from basic signing toward AI-assisted agreement analysis, repositories, workflow automation and agentic action. If IAM adoption continues to rise, Adobe may face pressure to prove that its own document intelligence and signing stack can match DocuSign’s agreement-specific depth and enterprise workflow integration.
These are strategic read-throughs, not claims that one quarter of DocuSign results will materially change either company’s near-term earnings. The more relevant industry signal is that eSignature is becoming a feature inside a broader AI-enabled agreement-management stack. Vendors that own the workflow, data context and integration layer are likely to capture more value than vendors that remain focused on the signature event alone.
Valuation Framework and Key Risks
Using a DOCU share price of approximately $67.37 around September 11, 2026 and a market capitalization near $12.86 billion, the valuation is not especially demanding relative to the company’s current cash generation. DocuSign ended Q2 with approximately $973 million of cash, cash equivalents and investments and had no outstanding borrowings under its revolving credit facility. That implies an enterprise value of roughly $11.9 billion.
Against the midpoint of FY2027 revenue guidance, $3.503 billion, the stock trades at roughly 3.4 times enterprise value to forward revenue. Calculation: approximately $11.9 billion enterprise value ÷ $3.503 billion revenue midpoint = about 3.4 times. This is calculated from company-reported balance-sheet and guidance figures combined with the contemporaneous market capitalization.
A cash-flow view is even more interesting. Fiscal 2026 free cash flow was $1.059 billion. Free cash flow for the first half of FY2027 was $585.2 million, compared with $445.5 million in the first half of FY2026. A simple trailing-12-month reconstruction therefore produces approximately $1.198 billion of free cash flow: $1.059 billion + $585.2 million – $445.5 million = about $1.198 billion. This is calculated from company-reported figures. On that basis, enterprise value is roughly 9.9 times trailing-12-month free cash flow.
That valuation leaves room for upside if IAM can push ARR growth into a sustained double-digit range without sacrificing the low-30s operating-margin profile. However, investors should not treat the cash-flow multiple as risk-free. DocuSign continues to issue significant stock-based compensation, with Q2 stock-based compensation of $148.6 million equal to roughly 17.0% of revenue, calculated from company-reported figures. The company is also using substantial cash for repurchases: $624.0 million of stock was repurchased in the first six months of FY2027, slightly more than the $585.2 million of free cash flow generated over the same period.
There are five core risks to the valuation. First, IAM could cannibalize existing eSignature or CLM spend rather than create enough incremental ARR. Second, gross margin could remain under pressure if AI workloads, cloud migration and model inference costs scale faster than expected. Third, large AI platforms could capture more of the user interface and bargaining power even if they use DocuSign as an underlying agreement layer. Fourth, a portion of non-GAAP profitability excludes stock-based compensation, which remains economically meaningful. Fifth, the current re-rating depends on expansion improving from 103% DNR; if that metric stalls, investors may conclude that the IAM transition is strategically interesting but financially insufficient to change the growth regime.
The valuation therefore reflects a market that is giving DocuSign credit for cash generation and execution, but not yet full credit for an AI-driven growth reacceleration. That is reasonable. The company has shown a stronger pipeline of evidence, but the next two quarters need to confirm that IAM’s rising ARR contribution translates into total ARR growth, expansion and revenue acceleration rather than simply a better product mix inside a still-mature growth profile.
3. Key FAQs
Did DocuSign beat Q2 2027 earnings estimates?
Yes. DocuSign reported Q2 FY2027 revenue of $875.7 million versus roughly $867.2 million expected and non-GAAP diluted EPS of $1.16 versus approximately $1.09 expected. Non-GAAP operating margin was 31.6%, also well above the company’s prior 29.7%-30.2% guidance range. The more important beat, however, was qualitative: IAM adoption accelerated, DNR improved to 103%, and management raised full-year ARR guidance.
What is DocuSign’s Q3 2027 and FY2027 guidance after the Q2 earnings report?
For Q3 FY2027, DocuSign expects revenue of $886 million-$890 million, non-GAAP gross margin of 81.5%-81.9%, and non-GAAP operating margin of 31.3%-31.7%. For the full fiscal year ending January 31, 2027, it expects revenue of $3.499 billion-$3.507 billion, ARR growth of 8.5%-9.0%, non-GAAP gross margin of 81.5%-82.0%, and non-GAAP operating margin of 31.0%-31.5%. IAM is expected to represent 18%-19% of total ARR exiting Q4.
Is DOCU stock undervalued after Q2 2027 earnings?
At roughly $67 per share, DOCU trades near 3.4 times enterprise value to the midpoint of FY2027 revenue guidance and around 9.9 times reconstructed trailing-12-month free cash flow, based on the calculations above. Those multiples appear moderate for a software company with low-30s non-GAAP operating margins and a mid-30s free-cash-flow margin, but the discount is understandable because revenue growth is still in the high-single digits, stock-based compensation remains material, and the market still needs evidence that IAM can drive sustained expansion-led acceleration.
Primary sources: DocuSign Q2 FY2027 financial results, DocuSign Q2 FY2027 earnings-call transcript, DocuSign Form 10-Q for the quarter ended July 31, 2026, and the company’s official Investor Relations page.
Disclaimer: This article/chart is for educational and informational purposes only and does not constitute investment advice of any kind. Past performance is not indicative of future results. Investors should independently evaluate their own risks.
